Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
KAN-002 by Kanvas Biosciences for Inflammatory Bowel Disease: Likelihood of Approval
KAN-002 is under clinical development by Kanvas Biosciences and currently in Phase I for Inflammatory Bowel Disease. According to GlobalData,...